Strides Pharma Signs US Nasal Drug Products Deal with Kenox

Strides Pharma Science announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Singapore, has signed an agreement with Kenox Pharmaceuticals, a high-growth contract development and manufacturing organization with a focus on..

Sun Pharma & Lupin to develop affordable anti-obesity pills

India's prominent drug manufacturers Sun Pharmaceutical Industries and Lupin Ltd are advancing toward making affordable anti-obesity pills as the country faces a rapidly growing obesity epidemic. According to a report, the Drugs Controller General...

Swiss AI Healthcare Firm Partners with Indian Startup for Diagnostics

In this modern age of Artificial Intelligence, it is important to provide the new age AI driven solutions to the society in the healthcare sector also. In a strategic move to strengthen healthcare innovation in India

Eli Lilly Wins USFDA Breakthrough for Olomorasib in Lung Cancer Therapy

Eli Lilly and Company has been given the Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for olomorasib combined with anti-PD-1 therapy Keytruda

Pfizer Partners DPIIT to Strengthen India's Healthcare Innovation Drive

The Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, has partnered with Pfizer Limited by signing a Memorandum of Understanding

India's Medtech Ecosystem Poised for Global Scale-Up Post-COVID

Local manufacturing has satisfied only 10 percent of domestic demand prior to the COVID outbreak. Now it is estimated at 30 and even on high end hardware around 20 percent.

Lupin Gets USFDA Nod for Generic Risperidone LAI with 180-Day Exclusivity

Pharmaceutical company Lupin Ltd today announced that the US Food and Drug Administration (USFDA), granted approval on its generic risperidone LAI extended-release injectable suspension (25 mg, 37.5 mg, and 50 mg single-dose vials) for the...

JP Nadda Inaugurates India MedTech Expo 2025 in New Delhi

The highly-anticipated India MedTech Expo 2025 was inaugurated this morning at Bharat Mandapam, Pragati Maidan, by Union Minister for Health & Family Welfare and Chemicals & Fertilizers, Jagat Prakash Nadda, with Union Minister of State for...

China Approves Hernexeos for Advanced HER2-Mutant Lung Cancer

The National Medical Products Administration (NMPA) of China has authorized Boehringer Ingelheim's Hernexeos (zongertinib tablets) as a monotherapy for the treatment of adult patients with non-small cell lung cancer (NSCLC) that is incurable, locally

Zydus Launches Trivalent Flu Vaccine VaxiFlu in India

In accordance with WHO guidelines, Zydus Lifesciences Ltd., a multinational healthcare organization that leads innovation, announced the introduction of its trivalent influenza (Flu) vaccine, VaxiFlu, for the first time in India. Every year, seasonal

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.